Finance

Lists
Why is BRVE down 4.29%?
Dive Deeper
BRVE:NASDAQ
Braveheart Bio Inc
$19.62
-4.29%
(-0.88) 1D
Nov 13, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BRVE...
Open
$20.41
High
$20.41
Low
$19.18
Mkt. cap
1.76B
Avg. vol.
398.73K
Volume
536.60K
52-wk high
$32.00
52-wk low
$16.70
EPS
-$1.02
No. of employees
49
Open
$20.41
High
$20.41
Low
$19.18
Mkt. cap
1.76B
Avg. vol.
398.73K
Volume
536.60K
52-wk high
$32.00
52-wk low
$16.70
EPS
-$1.02
No. of employees
49
News stories
From web sources and news partners
About Braveheart Bio Inc
CEO-
Employees49
Founded2024
HeadquartersSan Francisco, California, United States
SectorHealth Care
IndustryPharmaceutical industry
Websitebraveheart.bio
Analyst ratings
Based on 5 analysts giving stock ratings to BRVE in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for BRVE in the last 3 months.
Highest
Current $19.62
$49.00 (+149.75%)
Average
$45.50 (+131.91%)
Lowest
$40.00 (+103.87%)
Analyst
Recommendation
Action
Price target
Projected
Date
Salveen Richter
Goldman Sachs
Buy
Maintained
$49.00
+149.7%
11/11/2026
James Condulis
Stifel Nicolaus
Buy
Maintained
$45.00
+129.4%
11/09/2026
Olivia Brayer
Cantor Fitzgerald
Buy
Maintained
$40.00
+103.9%
11/07/2026
Tyler Van Buren
TD Cowen
Buy
Initiated
-
-
08/31/2026
Nimrod Tevet
Jefferies
Buy
Initiated
$48.00
+144.6%
08/31/2026
Andrew Tsai
Jefferies
Buy
Initiated
$48.00
+144.6%
08/31/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
9.00K
10.91M
11.12M
17.54M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
508.00K
4.14M
4.76M
12.61M
Operating expense
517.00K
15.05M
15.88M
30.15M
Total operating expenses
517.00K
15.05M
15.88M
30.15M
Operating income
-517.00K
-15.05M
-15.88M
-30.15M
Other non operating income
-
-2.00K
5.00K
-58.00K
EBT including unusual items
-59.12M
-14.28M
-14.99M
-26.50M
EBT excluding unusual items
-348.00K
-14.28M
-14.99M
-26.50M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-59.12M
-14.28M
-14.99M
-26.50M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
169.00K
771.00K
889.00K
3.71M
Interest expense
-
-
-
-
Net interest expenses
169.00K
771.00K
889.00K
3.71M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-15.05M
-15.88M
-30.15M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps